Press Releases
Homburger advised Addex Therapeutics Ltd on new PIPE transaction
On April 5, 2023, allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has completed an equity financing transaction with a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 7,999,998 shares in the form of 1,333,333 American Depositary Shares («ADSs») at a gross purchase price of USD 0.95 per ADS, which is equivalent to CHF 0.145 per share. Each ADS represents six shares. Additionally, Addex has issued to the investor ordinary warrants to purchase up to 5,263,158 ADSs, as well as pre-funded warrants to purchase up to 3,929,825 ADSs in a concurrent private placement.
12 April 2023